NCT07010653

Brief Summary

Induction of labor (IOL) is a frequently performed procedure in obstetrics, aimed to achieve vaginal delivery when continuing the pregnancy is no longer advisable. A key determinant of IOL success is cervical ripening, particularly when the cervix is initially unfavorable. A range of preinduction methods is available, encompassing both mechanical and pharmacological approaches. Among mechanical techniques, the double balloon catheter (CRB) facilitates cervical dilation by applying direct pressure, which stimulates local prostaglandin release. In contrast, Dilapan-S, a synthetic osmotic dilator, works by gradually expanding through the absorption of cervical fluids, thereby applying gentle mechanical pressure. While both methods are widely used and generally considered safe, there is limited evidence directly comparing their effectiveness and patient-centered outcomes. Mechanical methods are associated with a lower risk of uterine hyperstimulation compared to pharmacological alternatives. The choice between CRB and Dilapan-S may significantly influence labor duration, cesarean delivery rates, maternal comfort, and hospital resource utilization. This study aims to fill the existing knowledge gap by directly comparing Dilapan-S and CRB for term preinduction, with a focus on clinical efficacy and maternal satisfaction.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
126

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Sep 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress55%
Sep 2025Dec 2026

First Submitted

Initial submission to the registry

May 12, 2025

Completed
27 days until next milestone

First Posted

Study publicly available on registry

June 8, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

June 8, 2025

Status Verified

May 1, 2025

Enrollment Period

1 year

First QC Date

May 12, 2025

Last Update Submit

May 29, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time from initiation of cervical ripening to time of delivery measure in hours and minutes

    from the time of beginning of cervical ripening to the time of delivery measure in hours and minutes

Secondary Outcomes (10)

  • Change in Bishop score after device removal

    From the time of beggining of cervical ripening to the time of removal of the device (CRB or dilapan S) 12 hours

  • Mode of delivery

    at the time of delivery

  • Need for additional ripening agent

    From removal of CRB or dilapanS to 96 hours after enrollment

  • Maternal discomfort assessed by VAS

    from CRB insertion or DilapanS removal (12 hours)

  • Apgar Score

    at the time of delivery

  • +5 more secondary outcomes

Study Arms (2)

Dilapan-S

EXPERIMENTAL

Dilapan-S Participants assigned to the Dilapan-S group will have 3 to 5 rods inserted under aseptic conditions. Placement will follow manufacturer instructions, and rods will remain in place for up to 12 hours unless spontaneous labor or device expulsion occurs earlier. Upon removal, cervical status will be assessed, and induction will continue with prostaglandins or oxytocin based on standard care

Device: Higroscopic Cervical ripening

Double Balloon Catheter (CRB)

ACTIVE COMPARATOR

Participants randomized to CRB will undergo insertion of a double balloon catheter with inflation of each balloon (approximately 80 mL saline each) according to established protocols. The catheter will remain for up to 12 hours or until spontaneous labor or expulsion. Post-removal management will mirror that of the Dilapan-S group.

Device: Cervical ripening via CRB

Interventions

Participants assigned to the Dilapan-S group will have 3 to 5 rods inserted under aseptic conditions. Placement will follow manufacturer instructions, and rods will remain in place for up to 12 hours unless spontaneous labor or device expulsion occurs earlier. Upon removal, cervical status will be assessed, and induction will continue with prostaglandins or oxytocin based on standard care.

Dilapan-S

Double Balloon Catheter (CRB) Participants randomized to CRB will undergo insertion of a double balloon catheter with inflation of each balloon (approximately 80 mL saline each) according to established protocols. The catheter will remain for up to 12 hours or until spontaneous labor or expulsion. Post-removal management will mirror that of the Dilapan-S group.

Double Balloon Catheter (CRB)

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Singleton pregnancy
  • Cephalic fetal presentation
  • Gestational age ≥ 37+0 weeks
  • Indication for labor induction (e.g., postdates, maternal hypertension)
  • Bishop score ≤ 6
  • Maternal age ≥18 years
  • Ability to provide informed consent

You may not qualify if:

  • Premature rupture of membranes (PROM)
  • Placenta previa, vasa previa, or abnormal placentation
  • Active genital tract infection
  • Prior classical cesarean section or extensive uterine surgery
  • Known fetal anomaly contraindicating vaginal delivery
  • Allergy or sensitivity to device materials
  • Any contraindication to labor induction or vaginal birth

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Giuseppe RIZZO, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Giuseppe Rizzo

Study Record Dates

First Submitted

May 12, 2025

First Posted

June 8, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

June 8, 2025

Record last verified: 2025-05